fate therapeutics stock price target

Shares of Fate Therapeutics stock opened at 3694 on Wednesday. Wednesday December 15 2021.

Fate Therapeutics Nasdaq Fate Quotes And News Summary Benzinga

Fate Therapeutics started at equal weight at Morgan Stanley MarketWatch.

. Fate Therapeutics upgraded to outperform from neutral at Wedbush price target raised to 74 from 71 MarketWatch. Ad Our Strong Buys Double the SP. Stock Price Forecast The 18 analysts offering 12-month price forecasts for Fate Therapeutics Inc have a median target of 9900 with a high estimate of 13500 and a low estimate of 4200.

For ratings consensus and a summary of stock price. FATE stock opened at 3694 on Wednesday. Analysts Set Fate Therapeutics Inc.

Fate Therapeutics stock price target cut to 75 from 125 at Truist MarketWatch. Fate Therapeutics stock price target raised to 88 from 55 at Wedbush Dec. The minimum target price for Fate Therapeutics analysts is 9526.

According to data from MarketBeat the company has a consensus rating of Buy and a consensus target price of 9300. FATE has a higher upside potential average analyst target price relative to current price than 100215 of stocks in the mid market cap category. HC Wainwright Adjusts Fate Therapeutics Price Target to 115 from 122 Keeps Buy Rati.

Thursday August 26 2021. Find the latest Fate Therapeutics Inc. Nasdaq AT CLOSE 400 PM EDT 041222.

ET by Tomi Kilgore Fate Therapeutics stock price target raised to 65 from 40 at Truist. With a pricesales ratio of 668 Fate Therapeutics Inc has a higher such ratio than 9685 of stocks in our set. Fate Therapeutics stock opened at 3305 on Friday.

The stock has a fifty day moving. In terms of how Fate Therapeutics Inc fares relative to Pharmaceutical Products stocks note that its average analyst price target is greater than 94038 of that group. NASDAQFATE Target Price at 9500 Brokerages Set Equinor ASA NYSEEQNR Price Target at 21688 K21 K21 Trading 31 Higher Over Last 7 Days.

AFTER HOURS 543 PM EDT 041222. Wedbush Adjusts Fate Therapeutics Price Target to 77 From 74 Keeps Outperform Ratin. FATE analyst stock forecast price target and recommendation trends with in-depth analysis from research.

The firm has a market cap of 316 billion a PE ratio of -1482 and a beta of 156. Get Fate Therapeutics alerts. 1y Target Est 9453 Fair Value is the appropriate price for the shares of a company based on its earnings and growth rate also interpreted as when PE Ratio Growth Rate.

Of note is the ratio of Fate Therapeutics Incs sales and general administrative expense to its total operating expenses. Based On Fundamental Analysis. With a target price of.

7 2020 at 718 am. Analyst Recommendations on FATE THERAPEUTICS INC. The average price target is 000 with a high estimate of.

According to MarketBeat the company currently has an average rating of Buy and an average target price of 9850. 46 rows Given the current short-term trend the stock is expected to fall. Today 200 Day Moving Average is the resistance level 6369.

Amount of Analyst Coverage Fate Therapeutics has only been the subject of 3 research reports in the past 90 days. The community is currently still undecided about Fate Therapeutics Inc. Fate Therapeutics stock forecasts are adjusted once a day based on the closing price of the previous trading day.

Morgan Stanley Adjusts Fate Therapeutics Price Target to 52 From 62 Maintains Equalw. 5 Wall Street analysts that have issued a 1 year FATE price target the average FATE price target is 9360 with the highest FATE stock price forecast at 11500 and the lowest FATE stock price forecast at 7400. Only 838 of US stocks have a lower such ratio.

Fate Therapeutics has a 1 year low of 2940 and a 1 year high of 9743. Fate Therapeutics upgraded to outperform from neutral at Wedbush price target raised to 74 from 71 Benzinga 38d 10 Biggest Price Target Changes For Wednesday Barclays boosted the price target on. Find the latest analyst research for Fate Therapeutics Inc.

According to analysts consensus price target of 9500 Fate Therapeutics has a forecasted upside of 1501 from its current price of 3798. With 2 Buy predictions and 0 Sell predictions. Stocks similar to Fate Therapeutics Inc in the Pharmaceutical.

50 Day Moving Average is the resistance level 434.

Fate Therapeutics Share Price Usd0 001